TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

AM REGENT

CardiovascularOncologyMetabolic
Generics

AM REGENT is a generic drug manufacturer focused on Cardiovascular, Oncology, Metabolic. Key products include INJECTAFER.

1972
Since
76
Drugs
-
Trials
528
Approved (2yr)